Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The regulation of mitogen-activated protein (MAP) kinase by
oxytocin
in cultured human uterine myometrial cells was investigated.
Oxytocin
caused the rapid stimulation of
MAP kinase
activity detected in 32P incorporation of MAP-2.
Oxytocin
also stimulated the phosphorylation of
MAP kinase
detected in incorporation of [32P]orthophosphate into
MAP kinase
. Furthermore,
oxytocin
induced the tyrosine phosphorylation of
MAP kinase
. The
oxytocin
-dependent increase in the tyrosine phosphorylation of
MAP kinase
displayed a transient time course and was dependent on the concentration of
oxytocin
applied to the cells. Furthermore, we examined the mechanism by which
oxytocin
induced
MAP kinase
phosphorylation. Islet-activating protein (100 ng/ml), which inactivates Gi/Go proteins, blocked the
oxytocin
-induced phosphorylation of
MAP kinase
. Moreover, 1 microM ritodrine, which is known to relax uterine muscle contraction, attenuated
oxytocin
-induced
MAP kinase
activity and phosphorylation. These results provide evidence that
oxytocin
acutely activates
MAP kinase
through an islet-activating protein-sensitive G-protein in human uterine myometrial cells, suggesting that this new pathway may play an important role in the biological action of
oxytocin
on these cells.
...
PMID:Oxytocin stimulates mitogen-activated protein kinase activity in cultured human puerperal uterine myometrial cells. 753 62
Oxytocin
causes the rapid tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in both human and rat puerperal uterine myometrial cultured cells. The potential role of the
MAP kinase
pathway in
oxytocin
action was investigated with the specific MAP kinase kinase (MEK) inhibitor, PD98059.
Oxytocin
stimulation of the tyrosine phosphorylation of
MAP kinase
in both human and rat cultured puerperal uterine cells was abolished by pretreatment of the cells with MEK inhibitor in a dose-dependent manner. Although MEK inhibitor had no effect on
oxytocin
-induced intracellular Ca2+ mobilization in either pregnant human or pregnant rat uterine cells, it partly inhibited
oxytocin
-induced pregnant rat uterine contraction in a dose-dependent manner. These results suggest that
MAP kinase
pathway may have some important roles in
oxytocin
-induced uterine contraction.
...
PMID:The role of mitogen-activated protein kinase in oxytocin-induced contraction of uterine smooth muscle in pregnant rat. 895 97
Oxytocin
(OT) induces PG synthesis by both uterine endometrial and amnion cells. We showed previously that CHO cells stably transfected with the rat oxytocin receptor (CHO-OTR cells) also synthesize PGE2 in response to OT. In the present work we have demonstrated that OTRs are coupled to both Gi and Gq/11, using immunoprecipitation of solubilized OTR complexes and ADP ribosylation. OT treatment caused the rapid phosphorylation of extracellular signal-regulated protein kinase 2 (
ERK2
or p42MAPK), which was partially inhibited by pertussis toxin (PTX), consistent with OTR-Gi coupling. The PTX-insensitive portion of
ERK2
phosphorylation was linked to Gq, as inhibitors of both phospholipase C (U-73122) and protein kinase C (GF-109203X) blocked OT-induced
ERK2
phosphorylation. OT-stimulated c-fos expression was also mediated by
ERK2
phosphorylation. The ERK-c-fos pathway has been shown to be associated with cell proliferation, but OT had no effect on [3H]thymidine uptake by CHO-OTR cells. However, inhibition of OT-induced
ERK2
phosphorylation with an ERK kinase inhibitor (PD-98059) markedly reduced OT-stimulated PGE2 synthesis, pointing to the importance of
ERK2
activation in OT action.
...
PMID:ERK2 mediates oxytocin-stimulated PGE2 synthesis. 957 24
Thymic
oxytocin
(OT) behaves as a cryptocrine signal targeted at the outer surface of thymic epithelial cell plasma membrane from where OT is able to interact with neurohypophysial peptide receptors expressed by pre-T cells. Immature T cells bear a receptor of the V1 subtype, while OT receptors are predominantly expressed by cytotoxic CD8+ lymphocytes. In both T cell types, neurohypophysial peptide receptors transduce OT via the phosphoinositide pathway. Protein tyrosine phosphorylation is an early event of T cell activation. Western blots of murine pre-T cells (RL12-NP line) proteins probed with anti-phosphotyrosine (PY-20) revealed a great number of proteins the phosphorylation of which increased either with OT or vasopressin treatment. Two were immunoprecipitated with anti-focal adhesion kinase (FAK) mAb 2A7 and were identified one as p125FAK and the other as a coprecipitating 130-kDa protein. The p125FAK is connected to the Ras/
MAPK
pathway and is also implicated in TCR/CD3 signalling in T cell. Another protein phosphorylated by OT in RL12-NP was identified as paxillin, a 68-kDa protein localised at focal adhesion sites and associated with p 125FAK. These results indicate that phosphorylation of focal adhesion kinase may be induced in pre-T cell by thymic OT.
...
PMID:Neurohypophysial peptides stimulate the phosphorylation of pre-T cell focal adhesion kinases. 958 98
A major action of
oxytocin
is to stimulate prostaglandin production in reproductive tissues. The two major enzyme systems involved are cytosolic phospholipase A2 (cPLA2), which catalyses the formation of arachidonic acid from membrane glycerophospholipids, and prostaglandin endoperoxide-H synthases-1 and -2, which allow conversion of arachidonic acid to prostaglandins. During gestation, the concentrations of all three enzymes rise in the rabbit amnion. Agonists, including
oxytocin
, increase cPLA2 activity, in part, by elevating intracellular Ca2+ concentration, which causes cPLA2 to be translocated from the cytosol to intracellular membrane binding sites. Cytosolic PLA2 is then activated by a
mitogen-activated protein kinase
(
MAPK
)-dependent step. Our studies have elucidated signal pathways involved in
oxytocin
-stimulated prostaglandin output in both rabbit amnion cells and Chinese hamster ovary cells stably transfected with the rat oxytocin receptor. The two cell types are alike with respect to
oxytocin
-stimulated intracellular Ca2+ transients, mediation via Gq, and the specific
MAPK
that catalyses the phosphorylation of cPLA2. However, they differ with respect to the mechanisms of upregulation of key enzymes involved in prostaglandin E2 synthesis. These findings illustrate the tiers of complementary mechanisms involved in
oxytocin
stimulation of prostaglandin E2, and the extent of the diversity in the cellular signalling pathways involved.
...
PMID:Signal pathways mediating oxytocin stimulation of prostaglandin synthesis in select target cells. 1079 6
Natural peptides displaying agonist activity on the orphan G protein-coupled receptor GPR54 were isolated from human placenta. These 54-, 14,- and 13-amino acid peptides, with a common RF-amide C terminus, derive from the product of KiSS-1, a metastasis suppressor gene for melanoma cells, and were therefore designated kisspeptins. They bound with low nanomolar affinities to rat and human GPR54 expressed in Chinese hamster ovary K1 cells and stimulated PIP(2) hydrolysis, Ca(2+) mobilization, arachidonic acid release,
ERK1
/2 and p38 MAP kinase phosphorylation, and stress fiber formation but inhibited cell proliferation. Human GPR54 was highly expressed in placenta, pituitary, pancreas, and spinal cord, suggesting a role in the regulation of endocrine function. Stimulation of
oxytocin
secretion after kisspeptin administration to rats confirmed this hypothesis.
...
PMID:The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. 1145 43
The actin cytoskeleton is important for stress fiber formation and contributes to the initiation and maintenance of smooth muscle contraction. To determine if
oxytocin
and lysophosphatidic acid (LPA) induce stress fiber formation, cultured human myometrial cells were exposed to
oxytocin
(10(-5) M) or LPA (10(-6) M), and filamentous (F) and globular (G) actin pools were stained with fluorescein isothiocyanate-phalloidin and Texas red DNase I, respectively. The F- to G-actin fluorescent-staining ratio was measured by fluorescence microscopy.
Oxytocin
and LPA increased stress fiber formation, as indicated by an increase in the F- to G-actin fluorescent-staining ratio. The Rho-kinase inhibitor Y-27632 markedly attenuated this increase.
Oxytocin
-induced stress fiber formation was completely inhibited in the presence of the
oxytocin
antagonist compound VI. Tyrosine kinase inhibition with tyrphostin A23 partially blocked the increase induced by
oxytocin
but had no effect on LPA-induced stress fiber formation. Stress fiber formation was not blocked by pertussis toxin,
mitogen-activated protein kinase
, or protein kinase C inhibitors. Our results show that human myometrial cells respond to
oxytocin
and LPA with the formation of stress fibers that may be involved in the maintenance of uterine contractions. Rho-kinase appears to be a key signaling factor in this pathway.
...
PMID:Oxytocin and lysophosphatidic acid induce stress fiber formation in human myometrial cells via a pathway involving Rho-kinase. 1146 6
Oxytocin
stimulates a rapid increase in ovine endometrial prostaglandin (PG) F2alpha synthesis. The overall objective of these experiments was to investigate the cellular mechanisms by which
oxytocin
induces endometrial PGF2alpha synthesis. The objective of experiment 1 was to determine whether G(i) proteins mediate
oxytocin
-induced PGF2alpha synthesis. Uteri were collected from four ovary-intact ewes on Day 14 postestrus. Caruncular endometrial explants were dissected and subjected to in vitro incubation. Pertussis toxin, an inhibitor of G(i) proteins, had no effect on the ability of
oxytocin
to induce PGF2alpha synthesis (P > 0.10). The objective of experiment 2 was to determine whether any of the three mitogen-activated protein kinases (MAPKs), extracellular signal regulated protein kinase (
ERK1
/2), c-Jun N-terminal/
stress-activated protein kinase
(
JNK
/
SAPK
), or p38
MAPK
, mediate
oxytocin
-induced PGF(2alpha) synthesis. Eleven ovary-intact ewes were given an injection of
oxytocin
(10 IU; i.v.; n = 5) or physiological saline (i.v.; n = 6) on Day 15 postestrus. Uteri were collected 15 min after injection and caruncular endometrium was dissected. Endometrial homogenates were prepared and subjected to Western blotting. Membranes were probed for both total and phosphorylated forms of all three classes of
MAPK
. All classes of
MAPK
were detected in ovine endometrium, but
oxytocin
treatment had no effect on the expression of these proteins (P > 0.10).
ERK1
/2 was the only phosphorylated
MAPK
detected and its concentrations were higher in
oxytocin
-treated ewes (P < 0.01). The objective of experiment 3 was to further investigate the role of
ERK1
/2 during
oxytocin
-induced PGF2alpha synthesis. Uteri were collected from four ovary-intact ewes on Day 14 postestrus. Caruncular endometrial explants were dissected and subjected to in vitro incubation. PD98059, a specific inhibitor of
ERK1
/2 activity, blocked the ability of
oxytocin
to stimulate PGF(2alpha synthesis in a dose-dependent manner (P < 0.05). These results indicate that the ovine oxytocin receptor is not coupled to G(i) proteins. These results indicate that
oxytocin
induces phosphorylation of
ERK1
/2 and that this
MAPK
appears to mediate
oxytocin
-induced PGF2alpha synthesis in ovine endometrium.
...
PMID:Cellular mechanisms by which oxytocin mediates ovine endometrial prostaglandin F2alpha synthesis: role of G(i) proteins and mitogen-activated protein kinases. 1156 37
Pituicyte stellation in vitro represents a useful model with which to study morphological changes that occur in vivo in these cells during times of high neurohypophysial hormone output. This model has helped us establish the hypothesis of a purinergic regulation of pituicyte morphological plasticity. We first show that ATP induces stellation in 37% of pituicytes, an effect that is secondary to the metabolism of ATP to adenosine. Adenosine-induced stellation of pituicytes appears to be mediated by A(1)-type receptors. The effect is independent of intracellular calcium and does not involve the
mitogen-activated protein kinase
pathway. The basal (nonstellate) state of pituicytes depends on tonic activation of a Rho GTPase because both C3 transferase (a Rho inhibitor) and Y-27632 (an inhibitor of p160Rho kinase) can induce stellation. Lysophosphatidic acid, a Rho activator, blocks the morphogenic effect of adenosine dose-dependently. Using a specific RhoA pull-down assay, we also show that downregulation of activated RhoA is the key event coupling A(1) receptor activation to pituicyte stellation, via F-actin depolymerization and microtubule reorganization. Finally, both vasopressin and
oxytocin
can prevent or reverse adenosine-induced stellation. The effects of vasopressin, and those of high concentrations of
oxytocin
, are mediated through V(1a) receptors. Placed within the context of the relevant literature, our data suggest the possibility of a purinergic regulation of pituicyte morphological plasticity and subsequent modulation of hormone release, with these hormones providing a negative feedback mechanism.
...
PMID:RhoA inhibition is a key step in pituicyte stellation induced by A(1)-type adenosine receptor activation. 1200 47
MAP (mitogen-activated protein) kinase (also called Erk 1/2) plays a crucial role in cell proliferation and differentiation. Its impact on secretory events is less well established. The interplay of protein kinase C (PKC), PI3-kinase and cellular tyrosine kinase with
MAP kinase
activity using inhibitors and compounds such as glucose, phorbol 12-myristate 13-acetate (PMA) and agonists of G-protein coupled receptors like gastrin releasing peptide (GRP),
oxytocin
(OT) and glucose-dependent insulinotropic peptide (GIP) was investigated in INS-1 cells, an insulin secreting cell line.
MAP kinase
activity was determined by using a peptide derived from the EGF receptor as a
MAP kinase
substrate and [32P]ATP. Glucose as well as GRP, OT and GIP exhibited a time-dependent increase in
MAP kinase
activity with a maximum at time point 2.5 min. All further experiments were performed using 2.5 min incubations. The flavone PD 098059 is known to bind to the inactive forms of MEK1 (
MAPK
/ERK-Kinase) thus preventing activation by upstream activators. 20 microM PD 098059 (IC50 = 5 microM) inhibited
MAP kinase
stimulated by either glucose, GRP, OT, GIP or PMA. Inhibiton ("downregulation") of PKC by a long term (22 h) pretreatment with 1 microM PMA did not influence
MAP kinase
activity when augmented by either of the above mentioned compound. To investigate whether PI3-kinase and cellular tyrosine kinase are involved in G-protein mediated effects on
MAP kinase
, inhibitors were used: 100 nM wortmannin (PI3-kinase inhibitor) reduced the effects of GRP, OT and GIP but not that of PMA; 100 microM genistein (tyrosine kinase inhibitor) inhibited the stimulatory effect of either above mentioned compound on
MAP kinase
activation. Inhibition of
MAP kinase
by 20 microM PD 098059 did not influence insulin secretion modulated by either compound (glucose, GRP, OT or GIP). [3H]Thymidine incorporation, however, was severely inhibited by PD 098059. Thus
MAP kinase
is important for INS-1 cell proliferation but not for its insulin secretory response with respect to major initiators and modulators of insulin release. The data indicate that
MAP kinase
is active and under the control of
MAP kinase
. PKC is upstream of a genistein-sensitive tyrosine kinase and probably downstream of a PI3-kinase in INS-1 cells.
...
PMID:Role of protein kinase C, PI3-kinase and tyrosine kinase in activation of MAP kinase by glucose and agonists of G-protein coupled receptors in INS-1 cells. 1236 12
1
2
3
4
5
6
7
8
9
10
Next >>